Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 137

    1.

    Ductal carcinoma in situ of the breast.

    Fonseca R, Hartmann LC, Petersen IA, Donohue JH, Crotty TB, Gisvold JJ.

    Ann Intern Med. 1997 Dec 1;127(11):1013-22. Review.PMID: 9412283 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.

    Sakorafas GH, Tsiotou AG.

    Cancer Treat Rev. 2000 Apr;26(2):103-25. Review.PMID: 10772968 [PubMed - indexed for MEDLINE]Related articles

    3.

    259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

    Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

    Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Epub 2007 Aug 9. Review.PMID: 17687650 [PubMed - indexed for MEDLINE]Related articles

    5.

    Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.

    Boyages J, Delaney G, Taylor R.

    Cancer. 1999 Feb 1;85(3):616-28.PMID: 10091735 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Ductal carcinoma in situ of the breast: correlation of pathologic and mammographic features with extent of disease.

    Coombs JH, Hubbard E, Hudson K, Wunderlich C, VanMeter S, Bell JL, Gwin JL.

    Am Surg. 1997 Dec;63(12):1079-83.PMID: 9393256 [PubMed - indexed for MEDLINE]Related articles

    7.

    Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.

    Poller DN, Silverstein MJ, Galea M, Locker AP, Elston CW, Blamey RW, Ellis IO.

    Mod Pathol. 1994 Feb;7(2):257-62.PMID: 7911998 [PubMed - indexed for MEDLINE]Related articles

    9.

    Optimal management of ductal carcinoma in situ of the breast.

    Sakorafas GH, Farley DR.

    Surg Oncol. 2003 Dec;12(4):221-40. Review.PMID: 14998563 [PubMed - indexed for MEDLINE]Related articles

    10.

    Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age.

    Van Zee KJ, Liberman L, Samli B, Tran KN, McCormick B, Petrek JA, Rosen PP, Borgen PI.

    Cancer. 1999 Nov 1;86(9):1757-67.PMID: 10547549 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.

    Kestin LL, Goldstein NS, Lacerna MD, Balasubramaniam M, Martinez AA, Rebner M, Pettinga J, Frazier RC, Vicini FA.

    Cancer. 2000 Feb 1;88(3):596-607.PMID: 10649253 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results.

    Kestin LL, Goldstein NS, Martinez AA, Rebner M, Balasubramaniam M, Frazier RC, Register JT, Pettinga J, Vicini FA.

    Ann Surg. 2000 Feb;231(2):235-45.PMID: 10674616 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast.

    Hillner BE, Desch CE, Carlson RW, Smith TJ, Esserman L, Bear HD.

    J Clin Oncol. 1996 Jan;14(1):70-7.PMID: 8558224 [PubMed - indexed for MEDLINE]Related articles

    14.

    Assessment of treatment for patients with primary ductal carcinoma in situ in the breast.

    Fish EB, Chapman JA, Miller NA, Link MA, Fishell E, Wright B, McCready DR, Hiraki GY, Ross TM, Hanna WM, Lickley HL.

    Ann Surg Oncol. 1998 Dec;5(8):724-32.PMID: 9869520 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: clinical outcome.

    Cox CE, Hyacinthe M, Gonzalez RJ, Lyman G, Reintgen D, Ku NN, Miller MS, Greenberg H, Nicosia SV.

    Ann Surg Oncol. 1997 Dec;4(8):644-9.PMID: 9416412 [PubMed - indexed for MEDLINE]Related articles

    16.

    Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.

    Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Arun B, Sneige N, Pusztai L, Buchholz TA, Sahin A, Hunt KK, Meric-Bernstam F, Ross MI, Ames FC, Kuerer HM.

    Cancer. 2006 Jan 1;106(1):42-50.PMID: 16333852 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature.

    Vicini FA, Recht A.

    J Clin Oncol. 2002 Jun 1;20(11):2736-44. Review.PMID: 12039936 [PubMed - indexed for MEDLINE]Related articles

    18.

    Patterns of treatment for ductal carcinoma in situ of the breast in Louisiana, 1988-1999.

    Wu X, Chen VW, Ruiz B, Andrews PA, Hsieh MC, Schmidt BA, Correa CN, Fontham ET.

    J La State Med Soc. 2003 Jul-Aug;155(4):206-13.PMID: 14506828 [PubMed - indexed for MEDLINE]Related articles

    19.

    Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age.

    Schouten van der Velden AP, Peeters PH, Koot VC, Hennipman A.

    Ann Surg Oncol. 2006 Jul;13(7):990-8. Epub 2006 May 22.PMID: 16788762 [PubMed - indexed for MEDLINE]Related articles

    20.

    Management of ductal carcinoma in situ.

    Vezeridis MP, Bland KI.

    Surg Oncol. 1994 Dec;3(6):309-25. Review.PMID: 7773449 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data